Share this article

Patient care

Non-medical prescription opioid use is a major public health problem.

In 2011, 5.1 million people in the United States were using opioids, 4.5 million of whom were using for non-medical purposes and 620,000 of whom were using heroin. 2.2 million of those using opioids were considered clinically dependent. 1.8 million of these dependent individuals were using for non-medical purposes, and 369,000 were using heroin. On the bright side, 750,000 of the nonmedical users sought treatment for their opioid dependence.

It is important to recognize that opioid dependence is a chronic disease, not a moral failing. Dependence causes dysfunction in neural circuits, which in turn leads to physical dependence, bio-psycho-social changes, pathological reward seeking, relief via substance use, and disregard for consequences. It is a potentially fatal disease, causing an increased risk of death via HIV/AIDS, suicide, overdose, infection, trauma, etc.

Fortunately, there are many medication-assisted treatment (MAT) options available for opioid dependence, including methadone, buprenorphine, a buprenorphine/naloxone combination, and Naltrexone. The Drug Abuse Treatment Act of 2000 revolutionized opioid dependence MAT by allowing for medical office-based treatment of opioid dependence. After this Act passed, patients could start choosing between private care and care provided in a public Methadone clinic setting. Clinicians must be certified to prescribe medications for opioid dependence treatment through Opioid Treatment Programs via SAMHSA.


More about Medication-Assisted Treatment

MAT is a rapidly increasing trend in the addiction field, and for good reason. Studies have shown that it reduces high-risk behaviors, crime, and drug-use. It provides positive health outcomes and progressive psycho-social functioning. Reduction in use correlates with retention in treatment and, in fact patients, retained in MAT actually reduced their risk by 75%.

MAT is broken up into three phases. During the “induction” phase, the goal is to eliminate opioid withdrawal symptoms and achieve a steady state. During the “stabilization” phase, the goal is to eliminate cravings and extinguish drug-seeking behaviors. During the “maintenance” phase, the goal is to resume normal functioning and continue medication.


Both physician and patient knowledge of Buprenorphine misuse and diversion have increased significantly since the drug hit the market. Some of the biggest issues clinicians face are doctor shopping and illegal resale/redistribution. Buprenorphine seems to be easier than Methadone to find illegally, perhaps because of the strict Methadone clinic policy of consumption within clinic walls. Unfortunately, because Buprenorphine can be consumed outside of the clinical setting, incidents of accidental ingestions by children are increasing. In 2011 there were roughly 1500 emergency department visits for buprenorphine ingestions, 9.5% of which led to hospitalizations and 2.2% of which were a result of opioid prescriptions.


Probuphine versus Buprenorphine

Probuphine, an implanted device, serves as an attractive alternative to sublingual Buprenorphine treatment of opioid dependence. The implant delivers a constant, low-level dose of Buprenorphine over the course of six months. It is a safe and effective product that can minimize risk of accidental ingestion, minimize misuse/abuse/diversion, stabilize blood levels over six months, reduce pill burden, and guarantee that the dose written is the dose taken. It is recommended for patients who are already stable on low-to-moderate doses of Buprenorphine and also fit one of the following criteria: high risk of diversion, poor adherence, lack of MAT access, hectic schedule, and households with children.

Two Dreams plans to implement a Probuphine implantation program in our Oak Park/Chicago office in the near future. In the meantime, we offer Suboxone treatment services that you can read more about here.

Sources Cited

Probuphine for Maintenance Treatment of Opioid Dependence PDF

Share this article


Call us at (708) 613-4750

or message us below and one of our caring counselors will reach out to you.

Light regulates circadian rhythms

Why and How We Live Rhythmically at Two Dreams

The chains of habit are generally too small to be felt until they are too strong to be broken

- Samuel Johnson

Every living organism has a natural rhythm. These rhythms are disrupted by illness, particularly drug and alcohol use. A drug can create false sleep. A drug can stimulate alertness. A drug can suppress appetite. Another can stimulate appetite.

The science behind living rhythmically, strategies that promote and restore natural rhythms, and the role of sleep, nutrition, meditation, and exercise in the 21st century approach to healing oneself in recovery are all important aspects of your journey at Two Dreams.

At Two Dreams the concept of living in the NOW (No Other Way) is central to living a life in recovery. Similarly, mindfulness is a state of active, open, non-judgmental attention on the present. Many treatment programs and practitioners are employing mindfulness in the care and management of patients with mood, anxiety, and substance use disorders- diseases and symptoms which tend to cluster together.

Read more ...